Title |
Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes / Urs Christen, Laetitia Pouzol, Mélanie Tunis, Anna Sassi, Camilla Tondello, Monika Bayer, Edith Hintermann, Daniel S. Strasser, Sabrina Schuldes, Ulrich Mentzel, Marianne M. Martinic |
|---|---|
Involved |
Urs Christen (Verfasser)
Laetitia Pouzol (Verfasser) Mélanie Tunis (Verfasser) Anna Sassi (Verfasser)
Camilla Tondello (Verfasser)
Monika Bayer (Verfasser) Edith Hintermann (Verfasser) Daniel S. Strasser (Verfasser) Sabrina Schuldes (Verfasser) Ulrich Mentzel (Verfasser) Marianne M. Martinic (Verfasser) |
Published |
Frankfurt am Main: Universitätsbibliothek Johann Christian Senckenberg |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
ACT-777991
CXCR3 antagonism anti-CD3 antibody combination therapy
plasma C-peptide
type 1 diabetes |
DDC notation |
|
Persistent identifier |
urn:nbn:de:hebis:30:3-833982 (URN) |
Further information |
In: Clinical and experimental immunology, 214.2023, 2, S. 131-143 |
Record ID |
1324754966 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: